Target intelligence / Profile preview

Coral snake venom toxin protein

Molecular classification
Other (mixture of toxins), Enzyme (phospholipase A2, metalloproteinase, serine protease), Toxin (three-finger toxin, Kunitz-type inhibitor, WAPrin-type, C-type lectin-like)
01

Overview

Coral snake venom toxin proteins are a diverse mixture of biologically active proteins and peptides found in the venom of coral snakes (especially of the genus Micrurus). The major protein groups include three-finger toxins (3FTx), phospholipases A2 (PLA2s), Kunitz-type serine protease inhibitors, WAPrin-type inhibitors, C-type lectin-like proteins, and occasional metalloproteinases[1][2][4]. These toxins act through multiple mechanisms—including blocking or disrupting neuromuscular signaling (neurotoxicity), lysing muscle cells (myotoxicity), degrading extracellular matrix and vasculature (hemotoxicity), and inhibiting serine proteases—ultimately leading to paralysis, respiratory failure, and tissue injury in envenomated victims[2][3]. Unlike a singular molecular target (such as a receptor or enzyme), "coral snake venom toxin proteins" collectively refer to a complex set of toxic targets rather than a discrete molecular entity. This complexity enables the venom to affect multiple physiological pathways simultaneously, complicating both clinical management and research targeting these components for novel drug leads[4]. Note: - This entry is considered incorrect as a "single target" because coral snake venom is a complex mixture containing numerous protein families, each with its own structure, function, and pharmacology, not a single molecular entity[2][4]. The answer would need to focus on a specific toxin (e.g., "Three-finger toxin from Micrurus species") for structured, target-level details.

Other names
Coral snake venom proteinsCoral snake toxinsMicrurus venom proteins
02

Mechanism of action

Antivenom: Binds to and neutralizes toxic proteins; Inhibitory antibodies (experimental): Targeting specific toxin families (e.g., 3FTx, PLA2)

03

Biological functions

NeurotoxicityCytotoxicityHemotoxicityInhibition of proteasesMuscle paralysisECM degradation
04

Disease associations

Other (snakebite envenomation)
05

Safety considerations

Extreme toxicity at low doses (neurotoxicity, respiratory paralysis, local tissue damage)Risk of anaphylaxis or serum sickness with antivenom therapyHigh variability and complexity limit drug development prospect
06

Interacting drugs

Antivenom (coral snake antivenom)

1 more in the full profile.

Beyond the preview

Go deeper on Coral snake venom toxin protein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Coral snake venom toxin protein.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call